VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Myeloma transplantation: 17p deletions & 4;14 translocations

Nico Gagelmann, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, discusses the findings from a Chronic Malignancies Working Party European Blood and Marrow Transplant (CMWP-EBMT) study evaluating upfront stem cell transplantation for newly diagnosed multiple myeloma with 17p deletions and 4;14 translocations. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter